Hoth Therapeutics Raises $2 Million Through Registered Direct Offering of Stock and Warrants

Hoth Therapeutics has announced a registered direct offering, raising $2.0 million through the sale of its common stock and warrants. The biopharmaceutical company disclosed details of the transaction on Wednesday, April 1, 2026, stating that it entered into definitive agreements with institutional investors to facilitate the offering.

According to the announcement, Hoth Therapeutics will issue shares of its common stock alongside accompanying warrants to purchase additional shares. The gross proceeds from this offering are expected to total $2.0 million before deducting fees associated with placement agents and other expenses related to the transaction. The company did not provide further information regarding how it plans to allocate or utilize the funds raised through this initiative.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 1, 2026

Author

GOAI